Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer

NCT00707304 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

742

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Talactoferrin
DRUG: Placebo

Sponsor

Agennix